Insmed | INSM - Заемный капитал





Заемный капитал Изменить Дата
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Cytokinetics USD 1.12B 957.23M 2025-12
DBV Technologies USD 0 0 2025-03
Gilead Sciences USD 22.14B 5M 2025-09
Heron Therapeutics USD 140.64M 975K 2025-12
Insmed USD 540.96M 1.24M 2025-12
Novartis USD 24.24B 174M 2025-09
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03